Results 241 to 250 of about 229,156 (278)
Some of the next articles are maybe not open access.

When IBD is not IBD

Scandinavian Journal of Gastroenterology, 2018
Entamoeba histolytica colitis can mimic Crohn's disease. However, a fulminant infection can be life-threatening, especially after exposure to systemic steroids. We present a case of the patient who was initially diagnosed with ileocolonic Crohn's disease, but developed a hepatic E histolytica abscess while undergoing anti-TNF therapy. After revision of
Bram Verstockt   +3 more
openaire   +2 more sources

IBD and spondyloarthritis: joint management

Nature Reviews Gastroenterology & Hepatology, 2015
Spondyloarthritis (SpA) is the most common extraintestinal manifestation of IBD. SpA symptoms are not always recognized in patients with IBD. Subsequently, patients with symptoms of SpA can be underdiagnosed, with effective treatment delayed. Cooperation between gastroenterologists and rheumatologists is necessary and, ideally, an integrated management
GIONCHETTI, PAOLO, RIZZELLO, FERNANDO
openaire   +3 more sources

Infections and IBD

Nature Clinical Practice Gastroenterology & Hepatology, 2008
An interaction between infection and IBD was identified soon after Crohn's disease and ulcerative colitis were first described. Since then it has become apparent that infectious agents are involved with both the etiopathogenesis and clinical course of IBD on several levels.
Peter M, Irving, Peter R, Gibson
openaire   +2 more sources

The IBD and PSC Phenotypes of PSC-IBD

Current Gastroenterology Reports, 2018
To review the characteristics of IBD and PSC that occur in association, as well as their reciprocal influences on disease evolution, in adult and pediatric populations.IBD co-existing with PSC is genetically and clinically distinct from IBD alone. It is frequently characterized by pancolitis, rectal sparing, and possibly backwash ileitis, as well as a ...
Amanda, Ricciuto   +2 more
openaire   +2 more sources

[IBD: Crohn's disease].

Recenti progressi in medicina, 2016
Crohn's disease (CD) is a chronic inflammatory disorder that primarily affects small intestine and colon and causes tissue damage. The aetiology of CD is unknown, but a large body of evidence suggests that the pathological process is driven by excessive immune response, which is direct against components of the luminal flora and sustained by defects in
Pallone F., Calabrese E.
openaire   +3 more sources

Probiotics and IBD.

Acta gastro-enterologica Belgica, 2013
The pathophysiology of inflammatory bowel disease is still incompletely understood. While the development of the immune system and the establishment of the microflora take place during infancy young patients often have a more severe and extensive disease.
De Greef, E.   +4 more
openaire   +2 more sources

Challenges in IBD Research 2024: Preclinical Human IBD Mechanisms

Inflammatory Bowel Diseases
Abstract Preclinical human inflammatory bowel disease (IBD) mechanisms is one of 5 focus areas of the Challenges in IBD Research 2024 document, which also includes environmental triggers, novel technologies, precision medicine, and pragmatic clinical research.
Matthew A Ciorba   +15 more
openaire   +2 more sources

Fishing for missing heritability in IBD

Nature Reviews Gastroenterology & Hepatology, 2015
A genetic predisposition to IBD is widely accepted; however IBD heritability is dependent on more than the simple additive risk of genetic variants. In a new study using zebrafish, convincing evidence is presented that alterations in the epigenetic regulation of TNF might contribute to the "missing heritability" of IBD.
openaire   +2 more sources

IBD in 2013: enriching the therapeutic armamentarium for IBD.

Nature reviews. Gastroenterology & hepatology, 2014
In 2013, several new IBD drugs, including golimumab and vedolizumab, have been approved or completed successful programmes, showing efficacy in both Crohn’s disease and ulcerative colitis. In addition, classic IBD drugs have been formulated for colonic delivery, such as budesonide MMX®, which was recently approved for mild-to-moderate ulcerative ...
Danese S, Peyrin-Biroulet L
openaire   +2 more sources

IBD

Journal of Pediatric Gastroenterology and Nutrition, 1993
openaire   +2 more sources

Home - About - Disclaimer - Privacy